Results 251 to 260 of about 25,315 (305)

The prognostic significance of HDL-associated apolipoproteins in ascitic fluid from patients with cirrhosis and spontaneous bacterial peritonitis. [PDF]

Sci Rep
Murad M, Reuken PA, Schubert K, Reißing J, Ibidapo-Obe O, Große K, Frissen M, Haedge F, El-Hassani M, von Bergen M, Bruns T.   +10 more
europepmc   +1 more source

APOC3 Promotes DGAT2-Dependent Triglyceride Accumulation in Hepatocytes During Early Metabolic Dysfunction. [PDF]

Biomolecules
Nguyen TN, Kim HJ, Shim HM, Kang J, Ha EY, Cho H, Park JH.   +6 more
europepmc   +1 more source

Dried blood spot sample extraction for metabolomics and proteomics profiling for clinical trials: a descriptive exploratory study. [PDF]

Sci Rep
Fägerstam S, Johansson E, Af Geijerstam P, Rådholm K, Ghafouri B.   +4 more
europepmc   +1 more source

Apolipoprotein B-48.

Methods in enzymology, 1996
Karpe, F, Hamsten, A, Uffelman, K, Steiner, G   +3 more
openaire   +2 more sources

Apolipoproteins A‐I and B in Obese Children

Journal of Pediatric Gastroenterology and Nutrition, 1989
Body mass index (BMI), the distribution of fat, birth weight, physical fitness, apolipoproteins (apo) A‐I and B, total cholesterol (TC), and high‐density lipoprotein cholesterol (HDLC) were studied in 38 obese 10− to 11‐year‐olds in comparison to 52 age‐matched controls.
T, Sveger, C E, Flodmark, G, Fex, N C, Henningsen   +3 more
core   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Update on apolipoprotein B

Current Opinion in Lipidology, 2021
Purpose of review The 2019 European Society of Cardiology/European Atherosclerosis Society Guidelines concluded that apolipoprotein B (apoB) was a more accurate measure of cardiovascular risk and a better guide to the adequacy of lipid lowering than low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein ...
Sniderman, A., Langlois, M., Cobbaert, C.   +2 more
openaire   +3 more sources

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study

European Journal of Clinical Investigation, 2000
Apolipoproteins B, A–I and Lp(a) have been proposed as independent predictors of subsequent ischaemic heart disease (IHD) improving on the prediction obtained by routine lipid measurements.
P M Sweetnam, C H Bolton, L G Downs
exaly   +2 more sources

Apolipoprotein A1 and B

Clinics in Laboratory Medicine, 2006
This article reviews the evidence showing that apolipoprotein (apo) B and A-1 are superior to the conventional cholesterol indices as analytes in laboratory practice, indices of the lipoprotein-related risk for vascular disease, and measures of the adequacy of low-density lipoprotein-lowering therapy.
Allan D, Sniderman, Santica M, Marcovina
openaire   +2 more sources

Associations between maternal mid-pregnancy apolipoprotein A-1, apolipoprotein B, apolipoprotein B/apolipoprotein A-1 ratio and preterm birth

Clinica Chimica Acta, 2022
Elevated lipid levels during pregnancy have been shown to be related to the risk of preterm birth. Despite the importance of apolipoprotein (Apo) in lipid metabolism and transportation, evidence regarding apolipoprotein levels during pregnancy and preterm birth is still limited. Therefore, we aim to investigate the associations between maternal ApoA-1,
Qing, Liu, Li, Wu, Lulin, Wang, Kai, Chen, Yuntao, Wu, Jianhong, Xia, Youjie, Wang   +6 more
openaire   +2 more sources

Apolipoprotein B polymorphism and altered apolipoprotein B concentrations in Congolese blacks

Clinical Genetics, 1991
The immunoreactivity of apolipoprotein B (apo B) in plasma obtained from 238 unrelated black African male subjects from the People's Republic of Congo was analysed by non‐competitive Enzyme Linked‐Immunosorbent Assay (ELISA) with monoclonal BIP 45 anti‐LDL antibody.
H J, Parra, F, Martin, F, Monard, N, Ngangoué, N, Copin, J M, Bard, M, Qafli, N, Vu Dac, P, Duriez, J C, Fruchart   +9 more
openaire   +2 more sources